EAGER: Red Blood Cell Membrane Camouflaged Nanoparticles for Drug Delivery
EAGER: Red Blood Cell Membrane Camouflaged Nanoparticles for Drug Delivery
批准号:
1216461
负责人:
Liangfang Zhang
金额:
$25.0万
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-03-01 至 2014-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ID: MPS/DMR/BMAT(7623) 1216461 PI: Zhang, Liangfang ORG: UC San DiegoTitle: EAGER: Red Blood Cell Membrane Camouflaged Nanoparticles for Drug DeliveryINTELLECTUAL MERIT: The research objective of this award is to study an innovative biomimetic nanoparticle platform that uses natural red blood cell (RBC) membranes, rather than conventional synthetic stealth biomaterials, to cloak synthetic nanoparticles for drug delivery. The approach taken will be to utilize a novel and revolutionary top-down strategy to functionalize nanoparticles by transferring the entire cellular 'utility coat' of an RBC onto the surface of drug nanocarriers. A nanoparticle thus modified is expected to exhibit similar physiologic behavior as its source cells. To achieve the primary goal, two specific research tasks will be pursued in the proposed project: (i) study the physicochemical and biological properties the RBC membrane cloaked polymeric nanoparticles, and (ii) explore effective approaches to incorporate targeting ligands on the surface of the RBC membrane cloaked nanoparticles for targeted drug delivery.BROADER IMPACTS: If successful, this project will develop an entirely new class of biomimetic nanoparticles that combines RBC membranes with synthetic biomaterials. Such a combination of natural cellular components with synthetic biomaterials presents an innovative approach to develop novel and powerful drug delivery nanocarriers and will have profound impacts on the fields of biomaterials research and nanotechnology drug delivery. Moreover, this work highly integrates research and education. Two education thrusts will be carried out during the period of this project: (i) The PI will create new courses to shape and impact the development of the first undergraduate curriculum in 'nanoengineering' in the Untitled States. This curriculum will be provided as a model for the development of similar programs at other institutions. (ii) The PI will collaborate with the UCSD ET-CURE Program to provide minority undergraduate students with stimulating research experiences. The PI will recruit 1-2 minority undergraduate students to work on this project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biomimetic Nanosponges to 'Lure and Kill' Phospholipase A2
-
批准号:1904702
-
项目类别:Standard Grant
-
资助金额:$45.0万
-
财政年份:2019
-
负责人:Liangfang Zhang
-
依托单位:
Macrophage Membrane-Coated Nanoparticles for Endotoxin Neutralization
-
批准号:1505699
-
项目类别:Continuing Grant
-
资助金额:$39.0万
-
财政年份:2015
-
负责人:Liangfang Zhang
-
依托单位:
Systematic Approaches to Scale-up of Biocompatible Drug Delivery Nanoparticles for High-Rate Production
-
批准号:1031239
-
项目类别:Standard Grant
-
资助金额:$35.0万
-
财政年份:2010
-
负责人:Liangfang Zhang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Red/ET重组BCAS1工程菌的构建及通过MUC2调控缓解仔猪腹泻的机制研究
-
批准号:2026JJ70027
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王雁灿
-
依托单位:
高质子选择性与高质子电导率的薄层复合阳离子交换膜的制备及其在反向电渗析(RED)技术中的应用研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:梅颖
-
依托单位:
RED重组酶与内源Ku蛋白在莱茵衣藻核基因同源重组定向改造中的相互作用分析
-
批准号:31870343
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:贾彬
-
依托单位:
利用Red/ET DNA重组工程改造蛋白酶体抑制剂syrbactins生物合成途径开发抗肿瘤药物
-
批准号:31670097
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2016
-
负责人:张友明
-
依托单位:
面向RED路由器队列的LDoS攻击检测和防御方法的研究
-
批准号:61601467
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:岳猛
-
依托单位:
λ Red系统引入抗性的去除与APEC突变株致病作用的放大
-
批准号:31272559
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:高崧
-
依托单位:
噬菌体Red重组系统用于高等植物叶绿体转化的研究
-
批准号:31060160
-
项目类别:地区科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:邹竹荣
-
依托单位:
Red sprites地基光学观测及其产生机理研究
-
批准号:40804028
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2008
-
负责人:杨静
-
依托单位:
用lambda Red功能进行哺乳类细胞基因替代的研究
-
批准号:30170522
-
项目类别:面上项目
-
资助金额:17.0万元
-
批准年份:2001
-
负责人:陈苏民
-
依托单位: